01601nam 2200421Ia 450 991069911530332120230902162029.0(CKB)5470000002400747(OCoLC)466422255(EXLCZ)99547000000240074720091117d2004 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] sterile drug products produced by aseptic processing, current good manufacturing practiceRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,[2004]1 online resource (59 pages)"Center for Biologics Evaluation and Research (CBER).""Office of Regulatory Affairs (ORA).""Pharmaceutical CGMPs.""September 2004."Includes bibliographical references (pages 54-55).Guidance for industry DrugsSterilizationUnited StatesAsepsis and antisepsisDrugsSterilizationAsepsis and antisepsis.Center for Drug Evaluation and Research (U.S.)Center for Biologics Evaluation and Research (U.S.)United States.Food and Drug Administration.Office of Regulatory Affairs.GPOGPOBOOK9910699115303321Guidance for industry3434577UNINA